Skip to content

The role of Yogic breathing techniques in progression and recovery from COVID-19.

The role of Yogic breathing techniques among quarantined HCWs, COVID-19 positive and COVID 19 convalescent patients: A randomized clinical trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/10/028195
Enrollment
72
Registered
2020-10-01
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere

Interventions

Intervention1: Yogic breathing: Yoga:SHORT DURATION BREATHING TECHNIQUE(SDBT) Time Interval : 3-5 minutes Preparation: eyes closed, sit with cross legs Process: Powerful inhalation/ exhalation (Bhast

Sponsors

Ministry of AYUSH Government of India
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: The Quarantined COVID-19 suspects, COVID-19 convalescent and COVID-19 positive patients will be enrolled in the study based on their quarantined venue, recovery or the admission to the hospital, as the case may be, after the initial screening as per the Institutes guidelines. Patients between the age group of 15 â?? 70 years will be considered for this study.

Exclusion criteria

Exclusion criteria: Pediatric cases upto the age of 14 year will not be recruited in this study. Subjects will not be recruited if they are yoga practitioners. COVID-19 patients on a ventilator and those with epilepsy, brain tumor, brain aneurysm, and pregnancy or those not cleared by medical opinion for the breathing techniques.

Design outcomes

Primary

MeasureTime frame
Anxiety, stress, post traumatic stress, triguna, tridosha, Mental wellbeing, wellness and resilience Timepoint: baseline, after 15 days

Secondary

MeasureTime frame
CBC, LFT, KFT, CRP, Procalcitonin, blood clotting timeTimepoint: All parameters will be assessed at baseline, after 7 days and after 15 days.;IgG, IgMTimepoint: 28th day from enrollment

Countries

India

Contacts

Public ContactDr Akshay Anand

PGIMER Chandigarh

akshay2anand@gmail.com09815968102

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 11, 2026